In this free webinar, learn about the latest trends in the biopharmaceutical market, and the implications for biotech decision makers. Attendees will learn the potential exits available to biotech and key considerations for creating optionality in the strategic pathway. The featured speakers will discuss best practices for value focused clinical development and strategic capital allocation to optimize asset success.
TORONTO, April 25, 2023 /PRNewswire-PRWeb/ -- The game has changed in biotech. Continued macroeconomic uncertainty has far reaching implications for the biopharma ecosystem. Access to capital remains low across the industry, and a successful deal with large pharma has become less likely for many. Companies who earlier would have been sellers, may now be progressing development through registrational studies — or all the way through to market. Stated another way, biotechs can no longer operate toward the single goal of being acquired by, or of licensing their assets to, large pharma — accordingly, players may need to develop products further than in the past, and therefore strategic pathway optionality needs to be weaved into and maintained throughout product and corporate development. With these new challenges come multifold new opportunities for value creation.
Syneos Health® and Treehill Partners are at the center of this landscape, devising concerted product, corporate and business development strategies with customers to navigate the evolving market.
In this webinar, the featured speakers will discuss strategic and operational implications for the biotech C-suite and share perspectives on how companies can succeed in an increasingly competitive environment.
The speakers also look to address some pressing questions such as: How far to go as a biotech (and in what circumstances); Value focused clinical development; Strategic capital allocation; And how patients may benefit in the long run from the evolution and increasing sophistication of the biotech ecosystem.
Register now to learn about new opportunities for biotechs for value creation.
Join Lee Taurman, Global Head of Syneos One, Syneos Health; Keith Ruark, SVP Strategic Business Development, Syneos Health; and Ali Pashazadeh, Founder, Treehill Partners, for the live webinar on Thursday, May 11, 2023, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit New Opportunities for Value Creation: How Biotechs Can Succeed in an Increasingly Competitive Market.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article